Demonstrate the lot-to-lot consistency of 3 consecutive production lots of an adjuvanted influenza vaccine candidate and evaluate the safety of an adjuvanted influenza vaccine candidate versus Fluarix administered intramuscularly in elderly.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
At a glance
- Drugs GSK 1247446A; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 27 Oct 2008 Actual end date changed from Dec 2006 to Jul 2006 as reported by Clinicaltrials.gov
- 23 Oct 2008 Study end date changed from 1 Jul 2006 to 1 Dec 2006 as reported by ClinicalTrials.gov.
- 19 Mar 2008 Status changed from in progress to completed.